IWM
EW icon

IMG Wealth Management’s Edwards Lifesciences EW Stock Holding History

IMG Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Buy
+18
New +$1.51K ﹤0.01% 474
2026
Q1 		– Sell
-34
Closed -$2.9K – 540
2025
Q4 		$2.9K Hold
34
– – ﹤0.01% 469
2025
Q3 		$2.64K Hold
34
– – ﹤0.01% 423
2025
Q2 		$2.66K Buy
+34
New +$2.54K ﹤0.01% 420

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

IMG Wealth Management's EW Position: Q2 2026 in Review

IMG Wealth Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 18 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #474 among its holdings. This is a return to the name: IMG Wealth Management previously reported a position in EW as recently as Q4 2025.

IMG Wealth Management first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.9K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • IMG Wealth Management held 18 shares of Edwards Lifesciences worth $1.63K as of Q2 2026.
  • Edwards Lifesciences was a new IMG Wealth Management position in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of IMG Wealth Management's portfolio in Q2 2026, its #474 holding.
  • IMG Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • IMG Wealth Management's Edwards Lifesciences position peaked at $2.9K in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.